Public annual accounts

Orifarm Belgium financials

Name: Orifarm Belgium financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Orifarm Belgium, with comparable measures and links to available source documents.

Company overview

Registry number

0736472401

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Orifarm Belgium

2025 versus 2024

Operating line: €1,093,546
EBITDA: €724,047
Total assets: €4,999,836
Equity: €729,475

EBITDA margin +66.2% · Equity ratio +14.6%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€1,093,546	€724,047	€4,999,836	€729,475	-
202431 Dec 2024	€779,664	€456,651	€5,742,296	€352,028	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report